Use of Bevacizumab Injections in Medicare Fee For Service in the IRIS® Registry

Saved in:
Bibliographic Details
Published inOphthalmology retina Vol. 5; no. 9; p. 935
Main Authors Repka, Michael X, Glasser, David B, Cohen, Cathy G, Li, Charles, Lum, Christine, Lum, Flora, Williams, George A
Format Journal Article
LanguageEnglish
Published United States 01.09.2021
Subjects
Angiogenesis Inhibitors - economics
Angiogenesis Inhibitors - therapeutic use
Bevacizumab - economics
Bevacizumab - therapeutic use
Drug Costs
Eye Diseases - drug therapy
Eye Diseases - economics
Fee-for-Service Plans - economics
Humans
Medicare
Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors
Registries
United States
United States
Online AccessGet more information

Cover

More Information
ISSN:2468-6530
DOI:10.1016/j.oret.2021.03.003